Nitroxide Antioxidant Modulation of Apoptosis Gene Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Age-related decrease in gene expression levels, particularly in genes associated with the apoptosis pathway, contributes to various diseases such as cancer, autoimmune diseases, and age-related conditions, which existing treatments fail to effectively address.

Innovation Solution

Administering an effective amount of a nitroxide antioxidant, such as 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, to human subjects over 35 years old with decreased expression levels of genes like Cd51, Perp, Unc5b, Bag5, or Bri3, to increase their expression levels in tissues like skin, adipose, and neuronal tissues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing treatments are used, then general disease symptoms are addressed, but age-related decrease in gene expression levels is not effectively reversed

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoidability to address age-related gene expression decrease
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent uses nitroxide antioxidants to change the biochemical parameters within cells, specifically targeting oxidative stress levels and mitochondrial function. This parameter change approach allows the treatment to specifically reverse age-related gene expression decreases in apoptosis pathway genes without affecting other disease conditions, thus resolving the contradiction between general effectiveness and age-specific adaptability

Inventive Principle:
Principle #35Parameter changes

2Reliability

If apoptosis levels are increased to treat age-related diseases, then disease symptoms are reduced, but uncontrolled cell death may occur

Engineering Contradiction:
Improvedisease treatment effectivenessVSAvoiduncontrolled cell death
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

Nitroxide antioxidants serve as intermediary substances that modulate the apoptotic pathway indirectly through reducing oxidative stress and improving mitochondrial function. This intermediary approach allows for controlled enhancement of apoptosis in aged cells without causing uncontrolled cell death, as the nitroxides regulate the process through biochemical modulation rather than direct activation

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The treatment creates a feedback mechanism where nitroxide antioxidants monitor and respond to cellular oxidative stress levels, dynamically adjusting the apoptotic response. This feedback control ensures that apoptosis is enhanced only when and where oxidative stress indicates cellular aging, preventing uncontrolled cell death while effectively treating age-related diseases

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The increased expression levels of these genes enhance apoptosis, leading to a reduction or disappearance of disease symptoms, potentially curing age-related diseases by counteracting decreased apoptosis levels.

Implementation Method 1

administering to the human subject an effective amount of a nitroxide antioxidant resulting in an increased expression level of the gene

Methodology Applied
Scientific EffectAntioxidant activity: Oxidation

Data Source

PatentUS9744162B1Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
Publication Date: 2017.08.29 HABASH LOUIS
  • US9744162B1 patent drawing
  • US9744162B1 patent drawing
  • US9744162B1 patent drawing

AI summary

Disclosed herein are methods for counteracting age-related decrease in gene expression or treating age-related diseases, for example cancers and autoimmune diseases, caused by decreased expression levels of a gene associated with the apoptosis pathway, using a nitroxide. Further disclosed are methods for treating a human subject in need of an increased expression level of a gene associated with the apoptosis pathway using a nitroxide.